期刊文献+

不同浓度博来霉素诱导硬皮病小鼠模型胃肠道并发症的病理研究

Pathological study of gastrointestinal complications in scleroderma model mice induced by different concentrations of Bleomycin
下载PDF
导出
摘要 目的探讨不同浓度博来霉素(BLM)诱导硬皮病小鼠模型胃肠道并发症的病理研究。方法选取雌性BALB/c小鼠18只,采用随机数字法将其分为空白对照组、模型1组和模型2组,各6只。空白对照组背部皮下注射0.1 ml磷酸缓冲液;模型1组注射0.1 ml 200μg/ml BLM;模型2组注射0.1 ml 500μg/ml BLM。三组均连续皮下注射28 d,1次/d。于第28天处死小鼠,观察比较三组小鼠背部注射区皮肤、食管、小肠组织切片的病理学特征,测定其血清D-乳酸(D-LA)和二胺氧化酶(DAO)水平。结果模型1组和模型2组真皮厚度均厚于空白对照组(P<0.05),模型2组真皮厚度厚于模型1组(P<0.05)。模型1组和模型2组食管、小肠胶原容积评分均高于空白对照组(P<0.05),模型2组食管、小肠胶原容积分数均高于模型1组(P<0.05)。模型1组和模型2组血清D-LA和DAO水平均高于空白对照组(P<0.05);模型2组血清D-LA和DAO水平均高于模型1组(P<0.05)。结论两种造模方法都能出现皮肤和肠道炎症浸润及纤维化改变,500μg/ml BLM诱导的硬皮病小鼠模型具有更明显皮肤和肠道病理改变。 Objective To investigate the pathological study of gastrointestinal complications induced by different concentrations of Bleomycin(BLM)in scleroderma model mice.Methods A total of 18 female BALB/c mice were divided into control group,model group 1,and model group 2 by random number table method,with six mice in each group.The control group were injected with 0.1 ml phosphate buffered saline subcutaneously on the back;the model group 1 were injected 0.1 ml 200μg/ml BLM;the model group 2 were injected 0.1 ml 500μg/ml BLM.Three groups were continuously injected for 28 days,once per day.On the 28th day,the mice were sacrificed,and the pathological features of the skin in the injected area,the esophagus,and the small intestinal tissue were observed.The serum levels of D-lactic acid(D-LA)and diamine oxidase(DAO)were gavaged.Results The dermis thickness in model group 1 and model group 2 were thicker than those in the control group(P<0.05),and the dermis thickness of model group 2 was thicker than that in model group 1(P<0.05).The collagen volume scores of the esophageal and small intestinal in model group 1 and model group 2 were higher than those in the control group(P<0.05),and the esophageal collagen volume scores in model group 2 were higher than those in model group 1(P<0.05).The serum levels of D-LA and DAO in model group 1 and model group 2 were higher than those in the control group(P<0.05),while the serum levels of D-LA and DAO in model group 2 were higher than those in model group 1(P<0.05).Conclusion Both modeling methods can show inflammatory infiltration and fibrotic changes in skin and intestine,and the 500μg/ml BLM-induced scleroderma model has more obvious changes in skin and intestinal pathological.
作者 黄奕 李永强 张泆琳 吕军影 HUANG Yi;LI Yongqiang;ZHANG Yilin;LYU Junying(The First College of Clinical Medicine,Guangxi Medical University,Guangxi Zhuang Autonomous Region,Nanning 530021,China;Department of Traditional Chinese Medicine,the First Affiliated Hospital of Guangxi Medical University,Guangxi Zhuang Autonomous Region,Nanning530021,China)
出处 《中国医药导报》 CAS 2023年第11期27-30,共4页 China Medical Herald
基金 广西壮族自治区自然科学基金重点项目(2018GXNSFDA281047) 广西壮族自治区中医药重点学科建设项目(GZXK-Z-20-52)。
关键词 硬皮病 动物模型 博来霉素 胃肠道 雌性BALB/c小鼠 Scleroderma Animal model Bleomycin Gastrointestinal tract Female BALB/c mice
  • 相关文献

参考文献6

二级参考文献45

  • 1张瑞,白明,范明明,申岚,苗明三.基于中西医临床病证特点的硬皮病动物模型分析[J].中药药理与临床,2019,0(6):170-175. 被引量:5
  • 2曹华,郑捷.局部注射博来霉素建立硬皮病小鼠模型的实验研究[J].中国皮肤性病学杂志,2007,21(8):469-473. 被引量:1
  • 3Young A, Khanna D. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014[J]. Curr Opin Rheumatol, 2015, 27(3): 241-248.
  • 4Koca SS, Ozgen M, Sarikava M, et al. Ghrelin prevents the development of dermal fibrosis in bleomycin-induced scleroderma[J]. Clin Exp Dermatal, 2014, 39(2): 176-181.
  • 5Maurer B, Distler A, Suliman YA, et al. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis[J]. Ann Rheum Dis, 2014, 73(10): 1880-1887.
  • 6Demir T, Turkbeyler I, Kaplan DS, et al. Effectiveness of palosuran in bleomycin-induced experimental scleroderma[J]. Inflammation, 2013, 36(1): 75-79.
  • 7Ek WE, Sahlqvist AS, Croo KS, et al. Mapping QLT affecting a systemic sclerosis-like disorder in a cross between UCD-200 and red jungle foul chicken[J]. Dev Comp Immunol, 2012, 38(2): 352-359.
  • 8Gerber EE, Gallo EM, Fontana SC, et al. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma[J]. Nature, 2013, 503(7474): 126-130.
  • 9Toshiyuki Y, Kiyoshi N. Animal model of sclerotic skin. V: increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma[J]. Clin Immunol, 2002, 102(1): 77-83.
  • 10Juniantito V, Izawa T, Yuasa T, et al. Immunophenotypical characterization of macrophages in rat bleomycin-induced scleroderma[J]. Vet Pathol, 2013, 50(1): 76-85.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部